Magellan Health, Inc. is maintaining its full year 2020 earnings guidance. The company expects the coronavirus pandemic will influence earnings seasonality in its business. The company now anticipates that the second quarter will produce strong operating results given the ongoing deferral of discretionary health care spending. The company is currently expecting the back half of 2020 will experience heavier than usual utilization as pent-up demand returns.